Company description

BGG is a global leader in the development and purification of high quality active natural plant ingredients for the food and beverage, dietary supplement, pharmaceutical and personal care industries. Founded in 1995, BGG employs a staff of approximately 400, has 5 production sites, international branches in North America, Japan, China and Switzerland and manages sales in more than 70 countries.

Key products for the food industry include: - Licorice and licorice derivatives: licorice powders and blocks, licorice flavonoids and licorice derivatives such as monoammonium glycyrrhizinate, glycyrrhizic acid. - Stevia derivatives, such as  Rebaudioside A, Rebaudioside D, total steviol glycosides, Glucosyl Stevioside and Vitosa® natural flavors and stevia sweeteners line.

Quick facts

Sales markets Africa; Asia; Australia; Central/South America; Eastern Europe; Middle East; North America; Western Europe
Primary business activity Manufacturer: Ingredients / Additives
Affiliated categories: Algae |Antioxidant |Aromas More

Upcoming events

14 may 2024

Vitafoods Europe 2024

14 - 16 May 2024 - Geneva, Switzerland Visit us at stand A99 Book a meeting See our Exhibitor Profile   See full Exhibitor List

News about BGG Europe SA

BGG Announces White Paper on ApplePhenon® by Renowned Doctor William Sears, MD

15 Nov 2021

BGG Announces White Paper on ApplePhenon® by Renowned Doctor William Sears, MD

Renowned health expert William Sears, MD has published a white paper on BGG’s ApplePhenon®, a unique apple extract high in polyphenols and antioxidants.  The white paper covers key information about ApplePhenon® with a focus on the extensive medical research on its health-giving properties.  ApplePhenon® has been the subject of over 50 published studies including 17 state-of-the-art human clinical trials.  Clinically-validated health benefits confirmed in this research inc...

Read more

15 Nov 2021

BGG Announces Results of a Human Clinical Study on a Synergistic Formula for Eye Health Containing MyrtiPro® Bilberry, AstaZine® Natural Astaxanthin and Lutein

BGG World (BGG) announced today that a new clinical trial1 conducted as a collaboration between BGG and one of Japan’s leading supplement brands was successfully completed and published on a synergistic combination containing 200mg MyrtiPro® BGG’s standardized bilberry extract containing 36% of anthocyanins by HPLC, 6mg Astazine® Natural Astaxanthin, and 10mg Lutein.  The registered, randomized, double-blind, placebo-controlled s...

Read more

15 Nov 2021

BGG Announces Results of a Human Clinical Study on MyrtiPro® Bilberry Extract: Positive Effects for Eye Fatigue in Video Display Terminal Users

BGG is extremely pleased to announce a new positive clinical trial publication related to MyrtiPro® for eye health.  Building on a previous clinical publication involving a synergistic Bilberry formula, the present study utilized 120mg of MyrtiPro® (BGG’s standardized Bilberry extract containing 36% anthocyanins by HPLC).  The registered, double-blind, placebo-controlled, randomized parallel-group study involved 32 healthy Japanese ad...

Read more

15 Nov 2021

BGG World Announces Completion of Astaxanthin Capacity Expansion and now has the World’s Largest Astaxanthin Farm

BGG World (BGG) and its subsidiary Algae Health Sciences (AHS) announce the completion of a major capacity expansion of their state-of-the-art, 100% glass tube photobioreactor microalgae farm.  This farm is now the largest Astaxanthin farm in the world.  The expansion doubles BGG’s Astaxanthin production capacity and will allow for fulfillment of customers’ demands for the next 3 – 5 years, after which adjacent land (wh...

Read more
BGG Europe SA

Contact information





View all contact information